Small Cap Losers: IPHA, BGRY, CURI

Innate Pharma SA (NASDAQ:IPHA) AstraZeneca (AZN) presented results from the COAST Phase 2 trial at the ESMO Congress. Results showed that monalizumab, co’s lead partnered asset, in combination with durvalumab improved progression-free survival and objective response rate compared to durvalumab alone in patients with unresectable, Stage III NSCLC who had not progressed after concurrent chemoradiation therapy. Based on results, AstraZeneca plans to start a registrational study with monalizumab in combination with durvalumab in patients with unresectable, Stage III NSCLC. Spiked to record highs.

Berkshire Grey Inc (NASDAQ: BGRY) spiked to two-week highs on above average volume, improving from recent record lows. In recent press, co earlier this week announced global availability of its Robotic Pick and Pack solutions. Berkshire Grey is an American technology company based in Bedford Massachusetts that develops integrated artificial intelligence and robotic solutions for e-commerce, retail replenishment, and logistics. The company’s systems automate pick, pack and sort operations.

Curiositystream Inc (NASDAQ: CURI) initiated with an Overweight and a $15 price target at JPMorgan. Curiosity Stream is an American factual media and entertainment company that offers video programming including documentaries, TV shows, and short form video content to subscribers. It was launched in 2015 by the founder of the Discovery Channel, John S. Hendricks.